MEN1 is characterized by the combined occurrence of parathyroid, pituitary and pancreatic neuroendocrine tumors, whereas MEN2 features medullary thyroid cancer in association with phaeochromocytoma and parathyroid tumors. Here, MEN1 is linked to pancreatic neuroendocrine tumor.